Death attributed to ventricular arrhythmia induced by thioridazine in combination with a single Contac C capsule.
Phenothiazines are known to produce electrocardiographic repolarization abnormalities. Thioridazine and mesoridazine appear to induce such changes more frequently than other neuroleptics and are also known to induce fatal ventricular arrhythmia. The woman described in this article died after taking her usual dose of thioridazine, 100 mg/d, in combination with a single capsule of Contac. C, a decongestant-antihistamine containing phenylpropanolamine and chlorpheniramine. Phenylpropanolamine, an ephedrine-like drug, was thought to have favoured the initiation by thioridazine of the ventricular arrhythmia that led to the woman's death. It is therefore suggested that ephedrine-like medications not be given to patients receiving thioridazine.
D000328:Adult; D002744:Chlorpheniramine / Q000009:adverse effects*; D004338:Drug Combinations; D004347:Drug Interactions; D005260:Female; D006801:Humans; D010665:Phenylpropanolamine / Q000009:adverse effects*; D013881:Thioridazine / Q000009:adverse effects*; D014693:Ventricular Fibrillation / Q000139:chemically induced*
D004338:Drug Combinations; D010665:Phenylpropanolamine; D002744:Chlorpheniramine; D013881:Thioridazine